281 related articles for article (PubMed ID: 33903133)
1. Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.
Day LB; Abdel-Qadir H; Fralick M
CMAJ; 2021 Apr; 193(17):E612-E615. PubMed ID: 33903133
[No Abstract] [Full Text] [Related]
2. Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.
Attena E; Albani S; Maraolo AE; Mollica M; De Rosa A; Pisapia R; Fiorentino G; Parrella R; Severino S; Russo V
Circ Arrhythm Electrophysiol; 2021 Jul; 14(7):e009811. PubMed ID: 34182791
[No Abstract] [Full Text] [Related]
3. Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients.
Lucijanic M; Bistrovic P
Clin Microbiol Infect; 2022 Apr; 28(4):619. PubMed ID: 34999175
[No Abstract] [Full Text] [Related]
4. Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
Singh A; Kamath A
Expert Opin Drug Saf; 2021 Dec; 20(12):1559-1564. PubMed ID: 34328807
[No Abstract] [Full Text] [Related]
5. Safety profile of the antiviral drug remdesivir: An update.
Fan Q; Zhang B; Ma J; Zhang S
Biomed Pharmacother; 2020 Oct; 130():110532. PubMed ID: 32707440
[No Abstract] [Full Text] [Related]
6. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
[No Abstract] [Full Text] [Related]
7. Remdesivir for patients with COVID-19.
Wu PE; Morris AM
CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097
[No Abstract] [Full Text] [Related]
8. Remdesivir for the treatment of COVID-19 in pregnancy.
Lampejo T
J Med Virol; 2021 Jul; 93(7):4114-4119. PubMed ID: 33788273
[No Abstract] [Full Text] [Related]
9. COVID-19 update: Remdesivir (Veklury) FDA-approved for children <12 years old.
Med Lett Drugs Ther; 2022 Jun; 64(1652):e1. PubMed ID: 35657368
[No Abstract] [Full Text] [Related]
10. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature.
Heck J; Stichtenoth DO; Mettin R; Jöckel J; Bickel C; Krichevsky B
Eur J Clin Pharmacol; 2021 Jan; 77(1):141-144. PubMed ID: 32761371
[No Abstract] [Full Text] [Related]
11. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19.
Kow CS; Aldeyab M; Hasan SS
Eur J Clin Pharmacol; 2021 Mar; 77(3):435-437. PubMed ID: 33011825
[No Abstract] [Full Text] [Related]
12. Remdesivir-associated bradycardia.
Ching PR; Lee C
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34479903
[TBL] [Abstract][Full Text] [Related]
13. Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).
Pallotto C; Suardi LR; Gabbuti A; Esperti S; Mecocci L; Blanc P
J Med Virol; 2021 May; 93(5):2631-2634. PubMed ID: 33620107
[No Abstract] [Full Text] [Related]
14. Remdesivir (Veklury) for COVID-19.
Med Lett Drugs Ther; 2020 Nov; 62(1612):186-188. PubMed ID: 33443491
[No Abstract] [Full Text] [Related]
15. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R; Kansagara DL; Marcucci M
Ann Intern Med; 2021 Feb; 174(2):229-236. PubMed ID: 33017175
[TBL] [Abstract][Full Text] [Related]
16. Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Hong YN; Xu J; Sasa GBK; Zhou KX; Ding XF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):541-548. PubMed ID: 33506946
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study.
Schreiber A; Bauzon JS; Batra K; Mohammed S; Lee K; Houshmand N; Pham U; Cosme C; Inciong K; Al-Taweel O; Nasser K; Rana J; Sossou C; Go A; Hawwass D; Diep J; Ahsan CH
Clin Drug Investig; 2022 Sep; 42(9):763-774. PubMed ID: 35978159
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir therapy associated with Bradycardia in SARS-CoV2.
Kumar S; Arcuri C; Chaudhuri S; Gupta R; Aseri M; Barve P; Shah S
Clin Cardiol; 2021 Sep; 44(9):1190-1191. PubMed ID: 34322890
[No Abstract] [Full Text] [Related]
19. Response to Özdemir Ö on "Kounis syndrome due to remdesivir allergy".
Beneki E; Dimitriadis K; Antonopoulos A; Aggeli K; Tsioufis K
Clin Toxicol (Phila); 2024 Apr; 62(4):275-276. PubMed ID: 38639134
[No Abstract] [Full Text] [Related]
20. Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19.
Shahrbaf MA; Tabary M; Khaheshi I
Cardiovasc Hematol Disord Drug Targets; 2021; 21(2):88-90. PubMed ID: 34387172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
